These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2166360)

  • 1. Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine.
    Nisar M; Watkin SW; Bucknall RC; Agnew RA
    Thorax; 1990 May; 45(5):419-20. PubMed ID: 2166360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isoniazid induced neuropathy: consider prevention].
    Steichen O; Martinez-Almoyna L; De Broucker T
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):157-60. PubMed ID: 16788441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotype and short-course chemotherapy for tuberculosis in Papua New Guinea.
    Currie B; Krause V; Mondia P; Hudson B
    P N G Med J; 1989 Dec; 32(4):259-62. PubMed ID: 2560598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 5. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we ban B6 supplementation of INH therapy in childhood tuberculosis?
    Mathur GP; Mathur S; Rastogi S
    Indian J Pediatr; 1993; 60(6):717-9. PubMed ID: 8200694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical mycobacterial infection of the lung in rheumatoid arthritis.
    Watkin SW; Bucknall RC; Nisar M; Agnew RA
    Ann Rheum Dis; 1989 Apr; 48(4):336-8. PubMed ID: 2712616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1983 Apr; 38(4):271-4. PubMed ID: 6867979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxine supplementation during isoniazid therapy.
    Snider DE
    Tubercle; 1980 Dec; 61(4):191-6. PubMed ID: 6269259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy secondary to isoniazid-induced pyridoxine deficiency.
    Aita JF; Calame TR
    Md State Med J; 1972 Oct; 21(10):68-70. PubMed ID: 4353461
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid induced motor-dominant neuropathy.
    Arsalan R; Sabzwari S
    J Pak Med Assoc; 2015 Oct; 65(10):1131-3. PubMed ID: 26440850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
    Gochi M; Kaneko Y; Seki A; Saitou Z; Samejima T; Seki Y; Takeda H; Kinoshita A; Kuwano K
    Kekkaku; 2012 Nov; 87(11):733-6. PubMed ID: 23367833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid induced early-onset of motor dominant neuropathy and treatment with high dose of pyridoxine.
    Choudhary CR; Kumari J; Advani M
    Indian J Tuberc; 2018 Apr; 65(2):175-176. PubMed ID: 29579435
    [No Abstract]   [Full Text] [Related]  

  • 16. A 32-year-old man with tuberculosis, fever, and rash.
    Story RE; Ditto AM
    Ann Allergy Asthma Immunol; 2004 May; 92(5):495-9. PubMed ID: 15191016
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 19. Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
    Trkanjec Z; Tekavec J
    Tuber Lung Dis; 1993 Feb; 74(1):16-9. PubMed ID: 8495013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid and ethambutol as a cause of optic neuropathy.
    Jimenez-Lucho VE; del Busto R; Odel J
    Eur J Respir Dis; 1987 Jul; 71(1):42-5. PubMed ID: 3115809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.